Summary
BNY Mellon's third-quarter 2009 10-Q filing indicates a stable operational outlook, particularly concerning legal proceedings. The company stated that while numerous legal actions and regulatory matters are ongoing, they do not anticipate any material adverse effects on the consolidated financial position or liquidity, although individual periods' net income could be impacted. This suggests a degree of confidence in managing litigation risks. Regarding capital management, the company repurchased a small number of shares (82,000) during the quarter, primarily to cover employee tax obligations related to stock vesting. This represents a minimal capital return to shareholders and is distinct from the broader share repurchase program authorized in 2007, under which a substantial portion of shares remained available for repurchase. Investors should note the company's ongoing commitment to defending legal claims and its conservative approach to share repurchases during this period.
Financial Highlights
39 data points| Revenue | -$1.51B |
| Operating Income | -$1.53B |
| Interest Expense | $113.00M |
| Net Income | -$2.46B |
| EPS (Basic) | $-2.05 |
| EPS (Diluted) | $-2.05 |
| Shares Outstanding (Basic) | 1.20B |
| Shares Outstanding (Diluted) | 1.20B |
Key Highlights
- 1The company does not believe that pending or potential legal actions or regulatory matters, individually or in aggregate, will materially adversely affect its consolidated financial position or liquidity, after accounting for reserves and insurance.
- 2While litigation outcomes are difficult to predict, they could materially affect net income in a given period.
- 3BNY Mellon repurchased 82,000 shares of common stock during the third quarter of 2009 for approximately $2 million, primarily related to employee tax payments upon vesting of restricted stock.
- 4These repurchases were not part of the publicly announced share repurchase program.
- 5As of September 30, 2009, 33.8 million shares remained available for repurchase under the December 2007 authorization.
- 6There is no expiration date on the previously authorized share repurchase program.
- 7The company is filing an amended and restated By-Laws and forms of indemnification agreements with directors and executive officers as exhibits to this report.